(Q46972643)

27 December 2017

title

Individualized mycophenolate mofetil dosing based on drug exposure significantly improves patient outcomes after renal transplantation (English)

1 reference

27 December 2017

1 reference

2

M Büchler

1 reference

27 December 2017

Y Le Meur

1

1 reference

27 December 2017

A Thierry

3

1 reference

27 December 2017

S Caillard

4

1 reference

27 December 2017

F Villemain

5

1 reference

27 December 2017

S Lavaud

6

1 reference

27 December 2017

I Etienne

7

1 reference

27 December 2017

P-F Westeel

8

1 reference

27 December 2017

B Hurault de Ligny

9

1 reference

27 December 2017

L Rostaing

10

1 reference

27 December 2017

E Thervet

11

1 reference

27 December 2017

J C Szelag

12

1 reference

27 December 2017

J-P Rérolle

13

1 reference

27 December 2017

A Rousseau

14

1 reference

27 December 2017

G Touchard

15

1 reference

27 December 2017

P Marquet

16

1 reference

27 December 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

27 December 2017

American Journal of Transplantation

published in

1 reference

27 December 2017

volume

7

1 reference

27 December 2017

issue

11

1 reference

27 December 2017

page(s)

2496-2503

1 reference

27 December 2017

Review of major clinical trials with mycophenolate mofetil in renal transplantation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Therapeutic drug monitoring of immunosuppressant drugs in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Clinical pharmacokinetics of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Immunosuppressive activity of mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Mycophenolic Acid Pharmacodynamics and Pharmacokinetics Provide a Basis for Rational Monitoring Strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Therapeutic drug monitoring of mycophenolate mofetil in transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Early adequate mycophenolic acid exposure is associated with less rejection in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Influence of cyclosporine on the serum concentration and biliary excretion of mycophenolic acid and 7-O-mycophenolic acid glucuronide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Higher exposure to mycophenolic acid with sirolimus than with cyclosporine cotreatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Twelve-month evaluation of the clinical pharmacokinetics of total and free mycophenolic acid and its glucuronide metabolites in renal allograft recipients on low dose tacrolimus in combination with mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2007.01983.X

10.1111/J.1600-6143.2007.01983.X

21 January 2018

Identifiers

DOI

1 reference

27 December 2017

1 reference

27 December 2017